ArticleCancer communications (London, England)2021

Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.

Ya Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.